Affinage

PCLO

Protein piccolo · UniProt Q9Y6V0

Length
5142 aa
Mass
560.7 kDa
Annotated
2026-06-10
22 papers in source corpus 7 papers cited in narrative 8 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 3/3 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PCLO encodes Piccolo, a large presynaptic cytoskeletal scaffolding protein of the active zone whose distinct homology domains overlap only partially with the related active zone protein Bassoon, indicating related but non-redundant functions at sites of neurotransmitter release (PMID:12175852). Piccolo regulates excitatory presynaptic function through a C-terminal region that includes calcium-sensing, PDZ, and C2 domains: a knock-in variant near the calcium-sensing domain raises synaptic Piccolo levels and increases excitatory synaptic transmission by ~30% without altering calcium-dependent phospholipid binding, synaptic vesicle accumulation, or in vitro synapse formation (PMID:26045179), and Piccolo loss reduces expression of the presynaptic cytomatrix partners CtBP1 and Bassoon (PMID:42038819). An astrocyte-specific Piccolo isoform localizes partly to the Golgi, where its loss fragments the Golgi, impairs secretion of the extracellular matrix components Brevican and Tenascin-R, and reduces synapse density in co-cultured neurons—a deficit rescued by wild-type astrocyte-conditioned medium—revealing a non-neuronal, secretory role in supporting synaptogenesis. A homozygous nonsense mutation eliminating the C-terminal PDZ and C2 domains is causative for the autosomal recessive neurodegenerative disorder pontocerebellar hypoplasia type 3 (PMID:25832664).

Mechanistic history

Synthesis pass · year-by-year structured walk · 8 steps
  1. 2002 Medium

    Established the molecular identity of Piccolo as a presynaptic active zone scaffold and resolved its domain architecture relative to Bassoon, defining whether the two proteins are redundant.

    Evidence cDNA cloning and cross-species sequence/domain comparison with gene structure characterization

    PMID:12175852

    Open questions at the time
    • No functional mutagenesis to assign roles to specific domains
    • Domain homology inferred from sequence, not from structural or biochemical assay
    • Distinct-versus-shared functions with Bassoon not tested experimentally
  2. 2013 Medium

    Tested how a non-coding PCLO variant could alter gene output, showing an intronic SNP modulates splicing efficiency rather than protein coding sequence.

    Evidence Minigene splicing assay comparing alleles with bioinformatic splice-site prediction

    PMID:24167553

    Open questions at the time
    • No protein-level validation of altered isoform abundance
    • Effect shown in minigene, not endogenous context
    • Functional consequence for neurons not addressed
  3. 2015 High

    Linked a specific Piccolo variant near the calcium-sensing domain to a quantitative gain in excitatory transmission, distinguishing protein-level effects from vesicle/synapse-formation effects.

    Evidence Pclo-SA/SA knock-in mouse with immunostaining, electrophysiology, phospholipid-binding and synapse-formation assays

    PMID:26045179

    Open questions at the time
    • Mechanism connecting increased Piccolo levels to increased transmission unresolved
    • Calcium-dependent phospholipid binding unchanged, leaving domain function unexplained
    • In vivo behavioral or circuit-level consequences not assessed
  4. 2015 Medium

    Demonstrated that complete loss of Piccolo C-terminal function causes human neurodegenerative disease, establishing PCLO as causative for pontocerebellar hypoplasia type 3.

    Evidence Linkage, whole-exome and Sanger sequencing with fetal brain RNA-seq in an affected pedigree

    PMID:25832664

    Open questions at the time
    • No in vitro or in vivo functional rescue of the mutation
    • Single pedigree
    • Cellular pathway from PCLO loss to cerebellar/pontine degeneration not defined
  5. 2021 Low

    Probed whether rare PCLO coding variants contribute to psychiatric disease, finding co-segregation of missense mutations with bipolar disorder and schizophrenia.

    Evidence Whole-genome sequencing with family co-segregation and in silico pathogenicity prediction

    PMID:34834409

    Open questions at the time
    • No functional or biochemical validation of the specific variants
    • Co-segregation in limited families with in silico support only
    • Causal mechanism in neurotransmission untested
  6. 2025 Low

    Addressed whether Piccolo regulates other presynaptic cytomatrix components, showing its loss reduces CtBP1 and Bassoon expression.

    Evidence CRISPR PCLO-knockout cell model with qPCR for CtBP1 and BSN

    PMID:42038819

    Open questions at the time
    • Single method (qPCR) without protein-level confirmation
    • Mechanism of transcriptional/expression regulation unknown
    • Not validated in neurons or in vivo
  7. 2025 Medium

    Revealed a non-neuronal role for an astrocyte-specific Piccolo isoform in Golgi-dependent ECM secretion required for synaptogenesis, broadening Piccolo function beyond the presynapse.

    Evidence Pclo gene-trap rat with RNA-seq, Golgi/ECM imaging, neuron-astrocyte co-culture electrophysiology, and conditioned-media rescue (preprint)

    Open questions at the time
    • Preprint not yet peer-reviewed
    • Molecular link between Piccolo and Golgi integrity unresolved
    • Identity of secreted factor(s) mediating rescue beyond Brevican/Tenascin-R not fully defined
  8. 2025 Medium

    Identified PCLO as an autoimmune antigenic target in the retina, indicating disease relevance beyond its structural synaptic role.

    Evidence Anti-retinal immunofluorescence, epitope mapping, bead assay, ELISpot, and TCR/BCR repertoire sequencing in sarcoid uveitis patients

    PMID:39892202

    Open questions at the time
    • Causal role of anti-PCLO autoimmunity in disease not established
    • Mechanism of PCLO exposure to immune surveillance unknown
    • Relationship to PCLO synaptic function unclear

Open questions

Synthesis pass · forward-looking unresolved questions
  • How Piccolo's calcium-sensing and C-terminal PDZ/C2 domains mechanistically couple synaptic vesicle dynamics, presynaptic protein homeostasis, and (in astrocytes) Golgi-dependent ECM secretion into a unified molecular pathway remains unresolved.
  • No structural model of the functional domains in complex with partners
  • Mechanism linking PCLO loss to pontocerebellar degeneration undefined
  • Domain-level dissection of neuronal versus astrocytic functions lacking

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005198 structural molecule activity 2 GO:0008092 cytoskeletal protein binding 1
Localization
GO:0005886 plasma membrane 2 GO:0005794 Golgi apparatus 1
Pathway
R-HSA-112316 Neuronal System 1 R-HSA-1266738 Developmental Biology 1
Partners
Complex memberships
presynaptic active zone cytomatrix

Evidence

Reading pass · 8 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2002 PCLO encodes Piccolo, a presynaptic cytoskeletal protein containing distinct homology domains, and comparison with Bassoon (a structurally related active zone protein) shows only subsets of domains are shared, indicating Piccolo and Bassoon perform related but distinct functions at presynaptic active zones as sites of neurotransmitter release. cDNA cloning, amino acid sequence comparison across human, mouse, rat, and chicken; gene structure characterization (25 coding exons over 380 kb) International journal of developmental neuroscience Medium 12175852
2013 The intronic SNP rs13438494 (C allele) in PCLO intron 24 reduces splicing efficiency of the PCLO minigene, acting by creating or disrupting splicing regulatory motifs (enhancer/silencer binding sites). Minigene splicing assay with A and C alleles; bioinformatics prediction of splicing regulatory sequences (Human Splice Finder) PloS one Medium 24167553
2015 The PCLO p.Ser4814Ala (rs2522833) variant, located near a calcium-sensing domain of Piccolo, increases synaptic Piccolo protein levels and produces ~30% increased excitatory synaptic transmission in cultured neurons; however, calcium-dependent phospholipid binding, synapse formation in vitro, and synaptic accumulation of synaptic vesicles were unaltered by this variant. Mouse knock-in model (Pclo-SA/SA), immunostaining for synaptic Piccolo levels, electrophysiology of cultured neurons, calcium-dependent phospholipid binding assay, in vitro synapse formation assay Neuroscience High 26045179
2015 A homozygous nonsense mutation in PCLO, predicted to eliminate the PDZ and C2 domains in the C-terminus of the protein, underlies pontocerebellar hypoplasia type 3 (PCH3), establishing that loss of PCLO function is causative for this autosomal recessive neurodegenerative disorder. Genome-wide SNP genotyping, linkage analysis, whole-exome sequencing, Sanger sequencing, human fetal brain RNA sequencing Neurology Medium 25832664
2021 Rare missense mutations in PCLO (Ser1535Leu and His5142Arg) co-segregate with bipolar disorder and schizophrenia respectively in affected families, implicating PCLO's role in regulating neurotransmission at the presynaptic cytomatrix in these disorders. Whole-genome sequencing, family co-segregation analysis, in silico pathogenicity prediction Journal of personalized medicine Low 34834409
2025 Piccolo loss of function (PCLO knockout via CRISPR) reduces expression of CtBP1 and BSN (Bassoon), indicating Piccolo regulates expression of other presynaptic cytomatrix genes. CRISPR-generated PCLO knockout cell model, real-time PCR for CtBP1 and BSN expression Galen medical journal Low 42038819
2025 An astrocyte-specific Piccolo isoform localizes partially at the Golgi; loss of Piccolo (Pclo gene trap rat model) causes fragmented Golgi in astrocytes, impaired secretion of extracellular matrix components Brevican and Tenascin-R, reduced synapse density in co-cultured neurons, and altered intrinsic neuronal network activity (increased mEPSC frequency); these synaptic deficits were rescued by conditioned medium from wild-type astrocytes. Pclo gene-trap rat model; RNA-seq; immunohistochemistry/immunocytochemistry for Piccolo isoform, Brevican, Tenascin-R, and GM130 (Golgi marker); neuron-astrocyte co-culture (Banker setup); electrophysiology (RRP, mEPSC, mIPSC); astrocyte-conditioned media rescue experiment bioRxivpreprint Medium
2025 Anti-PCLO autoantibodies and PCLO-reactive T-lymphocytes are detected in ARA-positive sarcoid uveitis patients, identifying PCLO as an autoimmune antigenic target in the retina. Indirect immunofluorescence for anti-retinal antibodies; HuScan linear epitope mapping; bead-based anti-PCLO antibody assay; ELISpot for PCLO-reactive T-lymphocytes; TCR/BCR repertoire next-generation sequencing Journal of autoimmunity Medium 39892202

Source papers

Stage 0 corpus · 22 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2013 Functional analysis of deep intronic SNP rs13438494 in intron 24 of PCLO gene. PloS one 51 24167553
2015 Loss of PCLO function underlies pontocerebellar hypoplasia type III. Neurology 48 25832664
2009 The PCLO gene and depressive disorders: replication in a population-based study. Human molecular genetics 38 19942622
2002 Gene structure and genetic localization of the PCLO gene encoding the presynaptic active zone protein Piccolo. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 32 12175852
2017 Genome-Wide Significance for PCLO as a Gene for Major Depressive Disorder. Twin research and human genetics : the official journal of the International Society for Twin Studies 22 28540843
2021 Identification of Rare Mutations of Two Presynaptic Cytomatrix Genes BSN and PCLO in Schizophrenia and Bipolar Disorder. Journal of personalized medicine 21 34834409
2012 PCLO gene: its role in vulnerability to major depressive disorder. Journal of affective disorders 19 22386049
2017 PCLO rs2522833-mediated gray matter volume reduction in patients with drug-naive, first-episode major depressive disorder. Translational psychiatry 17 28556829
2008 PCLO variants are nominally associated with early-onset type 2 diabetes and insulin resistance in Pima Indians. Diabetes 16 18647954
2010 PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder. The international journal of neuropsychopharmacology 12 20701824
2011 PCLO rs2522833 impacts HPA system activity in healthy young adults. Translational psychiatry 10 22832399
2015 Functional characterization of the PCLO p.Ser4814Ala variant associated with major depressive disorder reveals cellular but not behavioral differences. Neuroscience 9 26045179
2022 Characterization of PCLO Gene in Amazonian Native American Populations. Genes 6 35328053
2023 Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle. International journal of pharmaceutics 5 37598873
2023 Exploration of the Tumour Biological Significance of PCLO in Gastric Cancer: Results from a Large Central European Cohort. Pathobiology : journal of immunopathology, molecular and cellular biology 5 37935138
2013 Implications of a Chr7q21.11 Microdeletion and the Role of the PCLO Gene in Developmental Delay. Sultan Qaboos University medical journal 3 23862039
2025 Pontocerebellar Hypoplasia Type 3 With Two Novel PCLO Gene Mutations: A Case Report. Case reports in pediatrics 1 40661989
2025 PCLO Is Associated with Tumor Mutational Burden and Immunity in Patients with Oral Squamous Cell Carcinoma. Current issues in molecular biology 1 40699825
2014 No evidence for the association between a polymorphism in the PCLO depression candidate gene with memory bias in remitted depressed patients and healthy individuals. PloS one 1 25379724
2025 Anti-retinal immune response in sarcoid uveitis: A potential role for PCLO as an antigenic target. Journal of autoimmunity 0 39892202
2025 Novel Insights into Pontocerebellar Hypoplasia Type 3: Discovery of a New Disease-causing PCLO Variant and Development of a CRISPR-generated Cell Model : Novel Insights into Pontocerebellar Hypoplasia Type 3. Galen medical journal 0 42038819
2001 Genetic and molecular characterization of a variegating hsp70-acZ fusion gene in the euchromatic 31 B region of Drosophila melanogaster. Genome 0 11550907

Missed literature

Know a paper Affinage missed for PCLO? Flag it for the maintainers and the community.

No submissions yet.